<p>Naive CD8 T cells from WT or OX40 KO OT-I TCR transgenic mice were stimulated with APCs/peptide. On day 2/3, T cells were transduced with retroviral vectors expressing GFP, or GFP with A1. On day 5 of primary culture, GFP<sup>+</sup> CD8 T cells were sorted and adoptively transferred into naive C57BL/6 recipient mice that were subsequently challenged <i>i.p.</i> with whole OVA protein in PBS (filled bars) or PBS alone (open bars). (a) On days 5, 10, and 15, GFP<sup>+</sup>Vβ5<sup>+</sup>CD8<sup>+</sup> T cells were enumerated from pooled lymph nodes and spleen. Data are mean number of GFP<sup>+</sup>Vβ5<sup>+</sup>CD8<sup>+</sup> cells ± s.d from four individual mice and representative of three experiments (* <i>P</i><0.05, ** <i>P</i><0...
<p>The protocol of the experiment was as described in the legend of <a href="http://www.plospathogen...
<p><b>A</b>) Tumor model. 2.5×10<sup>6</sup> TRAMP-C1-mOVA tumor cells were injected into POET-1 mic...
<p>Mice primed with Lm-OVA were boosted 21 days later with the indicated dose of Lm-OVA. 5 days post...
<p>Naive CD8<sup>+</sup> T cells from WT or OX40 KO OT-I TCR transgenic mice were stimulated with AP...
<p>Naive CD8 T cells from WT or OX40 KO OT-I TCR transgenic mice were stimulated with T-depleted APC...
<p>Naive CD8 cells from WT or OX40 KO OT-I TCR transgenic mice were stimulated with peptide and APCs...
<p>(a) Naive CD8 T cells from WT OT-I TCR transgenic mice were stimulated <i>in vitro</i> with T-dep...
<p>GP33-specific TCR transgenic CD8<sup>+</sup> T cells, P14 cells, were obtained from naïve P14 Thy...
<p>(A) Experimental scheme. Naïve OVA-specific CD8 T cells were purified from WT or HVEM<sup>−/−</su...
<p>A. CD40-B cell vaccination generates CD8<sup>+</sup> Te cells but not Tm cells. 10<sup>6</sup> fe...
<p><b>A</b>) Purified naïve wild-type or OX40<sup>−/−</sup> OT-I T cells (1×10<sup>6</sup>/ml) were ...
<p>(A) C57BL/6 mice were primed with PBS or anti-DEC:OVA+anti-CD40, and boosted with anti-DEC:OVA+an...
<p>(A) <i>Hdac1<sup>f/f</sup></i> and <i>Hdac1<sup>f/f</sup>Cd4Cre</i> P14 CD8<sup>+</sup> T cells (...
<p>5×10<sup>4</sup> purified naïve CD45.1<sup>+</sup> WT CD8<sup>+</sup> OT-1 cells were adoptively ...
<p>Reconstituted TcRα<sup>−/−</sup> mice (described in <a href="http://www.plospathogens.org/article...
<p>The protocol of the experiment was as described in the legend of <a href="http://www.plospathogen...
<p><b>A</b>) Tumor model. 2.5×10<sup>6</sup> TRAMP-C1-mOVA tumor cells were injected into POET-1 mic...
<p>Mice primed with Lm-OVA were boosted 21 days later with the indicated dose of Lm-OVA. 5 days post...
<p>Naive CD8<sup>+</sup> T cells from WT or OX40 KO OT-I TCR transgenic mice were stimulated with AP...
<p>Naive CD8 T cells from WT or OX40 KO OT-I TCR transgenic mice were stimulated with T-depleted APC...
<p>Naive CD8 cells from WT or OX40 KO OT-I TCR transgenic mice were stimulated with peptide and APCs...
<p>(a) Naive CD8 T cells from WT OT-I TCR transgenic mice were stimulated <i>in vitro</i> with T-dep...
<p>GP33-specific TCR transgenic CD8<sup>+</sup> T cells, P14 cells, were obtained from naïve P14 Thy...
<p>(A) Experimental scheme. Naïve OVA-specific CD8 T cells were purified from WT or HVEM<sup>−/−</su...
<p>A. CD40-B cell vaccination generates CD8<sup>+</sup> Te cells but not Tm cells. 10<sup>6</sup> fe...
<p><b>A</b>) Purified naïve wild-type or OX40<sup>−/−</sup> OT-I T cells (1×10<sup>6</sup>/ml) were ...
<p>(A) C57BL/6 mice were primed with PBS or anti-DEC:OVA+anti-CD40, and boosted with anti-DEC:OVA+an...
<p>(A) <i>Hdac1<sup>f/f</sup></i> and <i>Hdac1<sup>f/f</sup>Cd4Cre</i> P14 CD8<sup>+</sup> T cells (...
<p>5×10<sup>4</sup> purified naïve CD45.1<sup>+</sup> WT CD8<sup>+</sup> OT-1 cells were adoptively ...
<p>Reconstituted TcRα<sup>−/−</sup> mice (described in <a href="http://www.plospathogens.org/article...
<p>The protocol of the experiment was as described in the legend of <a href="http://www.plospathogen...
<p><b>A</b>) Tumor model. 2.5×10<sup>6</sup> TRAMP-C1-mOVA tumor cells were injected into POET-1 mic...
<p>Mice primed with Lm-OVA were boosted 21 days later with the indicated dose of Lm-OVA. 5 days post...